3 months glp 1 Compounded Semaglutide glp 1 3 month results

A team of researchers developed a nanostructure-based GLP-1R agonist capable of crossing the BBB that significantly attenuated neuroinflammation and memory loss in an A peptide-induced mouse model of AD by inhibiting the inflammatory responses of microglia and astrocytes (Zhao et al., 2022)

Patterson, J

P., Bonaros N., Bueno H., Bugiardini R., et al

Most researchers see initial results within 4-8 weeks, with the most dramatic changes occurring between weeks 12-24

The regions focus on evidence-based treatment protocols, with favorable reimbursement policies, is boosting wider adoption of GLP-1 drugs

The company is planning another Phase 2b trial to assess multiple monthly doses in obesity with preliminary data expected in ear-end-2025 or early-2026